Oncotarget is a weekly peer-reviewed open access medical journal that started out covering research from all aspects of oncology. The journal was first established in 2010 and was published originally by Impact Journals. Ever since Oncotarget launched it has expanded its platform and has become one of the biggest sources of information for research done in the world of Oncology.
How Does this Benefit World of Medical Research?
One of the drawbacks in research, especially in the medical field, is the access to information researchers have daily. There is a pervading sense of competition when it comes to research in this field when there shouldn’t be. This causes a rift between researchers since each one is aiming for that ‘next big breakthrough’ to help combat the disease. While the latter is certainly a worthy cause, it also creates an unnecessary wall between researchers to share valuable information with each other that could help with a new breakthrough.
This is where Oncotarget steps in by being an open access medical journal researchers and oncologists can refer too. The goal of the medical access journal is to have an impact on the research done by the authors. They cover a variety of topics in oncology and have continued to expand their ranks by accepting papers on topics beyond just this area of research.
Other topics Oncotarget is looking to expand into include the following:
- Cell Biology
Their mission is to take these scientific results and make them available as widely and rapidly as possible. Ensuring researchers across the globe have access to this research will help to have a greater impact on the information going into these topics. Bridging that gap between researchers so they can share information freely with peers helps to nurture the progress of science. Ultimately, through their medical journal Oncotarget helps to one day see life without disease for people across the globe. Oncotarget is published by Impact Journals.